Zena Werb
Impact in
- Cancer Research top 0.01%
- Protease and Inhibitor Mechanisms
- Immunology and Allergy top 0.01%
- Cell Adhesion Molecules Research
Papers in
- Cancer Research 180
- Protease and Inhibitor Mechanisms 157
-
- Wnt/β-catenin signaling in development and cancer 21
- Signaling Pathways in Disease 21
- Co-authors
- Lisa M. Coussens (12 shared papers)Mikala Egeblad (18 shared papers)Vicki Plaks (10 shared papers)Mark D. Sternlicht (13 shared papers)Kai Kessenbrock (13 shared papers)Pengfei Lu (10 shared papers)Valerie M. Weaver (8 shared papers)Andrew J. Ewald (20 shared papers)
- Journals
- Proceedings of the National Academy of Sciences (21 papers)Development (21 papers)The Journal of Experimental Medicine (21 papers)The Journal of Cell Biology (19 papers)Journal of Biological Chemistry (19 papers)
- Partner nations
- United StatesJapanCanada
In The Last Decade
Zena Werb
412 papers receiving 108.8k citations
Zena Werb's Hit Papers
Peers
Comparison fields: 5 of 195
- Cancer Research 30.3k
- Immunology and Allergy 11.3k
- Oncology 31.7k
- Immunology 17.1k
- Cell Biology 11.1k
Countries citing papers authored by Zena Werb
This map shows the geographic impact of Zena Werb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zena Werb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zena Werb more than expected).
Fields of papers citing papers by Zena Werb
This network shows the impact of papers produced by Zena Werb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zena Werb. The network helps show where Zena Werb may publish in the future.
Co-authors
The 25 scholars most cited alongside Zena Werb, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 416 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Inflammation and cancer Hit paper breakdown → | 2002 | 12280 |
| 2 | New functions for the matrix metalloproteinases in cancer progression Hit paper breakdown → | 2002 | 4987 |
| 3 | Matrix Metalloproteinases: Regulators of the Tumor Microenvironment Hit paper breakdown → | 2010 | 4063 |
| 4 | Remodelling the extracellular matrix in development and disease Hit paper breakdown → | 2014 | 3237 |
| 5 | How Matrix Metalloproteinases Regulate Cell Behavior Hit paper breakdown → | 2001 | 3227 |
| 6 | The extracellular matrix: A dynamic niche in cancer progression Hit paper breakdown → | 2012 | 2345 |
| 7 | Matrix metalloproteinases and the regulation of tissue remodelling Hit paper breakdown → | 2007 | 2333 |
| 8 | Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis Hit paper breakdown → | 2000 | 2230 |
| 9 | Lifeact: a versatile marker to visualize F-actin Hit paper breakdown → | 2008 | 1723 |
| 10 | Extracellular Matrix Degradation and Remodeling in Development and Disease Hit paper breakdown → | 2011 | 1704 |
| 11 | VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation Hit paper breakdown → | 1999 | 1657 |
| 12 | Concepts of extracellular matrix remodelling in tumour progression and metastasis Hit paper breakdown → | 2020 | 1517 |
| 13 | MMP-9/Gelatinase B Is a Key Regulator of Growth Plate Angiogenesis and Apoptosis of Hypertrophic Chondrocytes Hit paper breakdown → | 1998 | 1488 |
| 14 | Roles of the immune system in cancer: from tumor initiation to metastatic progression Hit paper breakdown → | 2018 | 1474 |
| 15 | Recruitment of Stem and Progenitor Cells from the Bone Marrow Niche Requires MMP-9 Mediated Release of Kit-Ligand Hit paper breakdown → | 2002 | 1368 |
| 16 | Netting neutrophils in autoimmune small-vessel vasculitis Hit paper breakdown → | 2009 | 1301 |
| 17 | The Cancer Stem Cell Niche: How Essential Is the Niche in Regulating Stemness of Tumor Cells? Hit paper breakdown → | 2015 | 1202 |
| 18 | Implantation and the placenta: key pieces of the development puzzle Hit paper breakdown → | 1994 | 1126 |
| 19 | ECM and Cell Surface Proteolysis: Regulating Cellular Ecology Hit paper breakdown → | 1997 | 1114 |
| 20 | MMP-9 Supplied by Bone Marrow–Derived Cells Contributes to Skin Carcinogenesis Hit paper breakdown → | 2000 | 1071 |
About Zena Werb
Zena Werb is a scholar working on Cancer Research, Molecular Biology, Oncology, Immunology and Immunology and Allergy, having authored 416 papers that have together received 111.2k indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (157 papers), Cell Adhesion Molecules Research (64 papers), Cancer Cells and Metastasis (59 papers), Peptidase Inhibition and Analysis (53 papers), Blood Coagulation and Thrombosis Mechanisms (43 papers), Immune cells in cancer (24 papers), Wnt/β-catenin signaling in development and cancer (21 papers) and Signaling Pathways in Disease (21 papers). The work is most often cited by research in Cancer Research (30.3k citations), Immunology and Allergy (11.3k citations), Oncology (31.7k citations), Immunology (17.1k citations) and Cell Biology (11.1k citations). Zena Werb has collaborated with scholars based in United States, Japan and Canada. Frequent co-authors include Lisa M. Coussens, Mikala Egeblad, Vicki Plaks, Mark D. Sternlicht, Kai Kessenbrock, Pengfei Lu, Valerie M. Weaver, Andrew J. Ewald, Thiennu H. Vu and Jonathan Chou. Their work appears in journals such as Proceedings of the National Academy of Sciences, Development, The Journal of Experimental Medicine, The Journal of Cell Biology and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.